These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 24111539)

  • 1. microRNA therapeutics in cardiovascular disease models.
    Dangwal S; Thum T
    Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs in cardiovascular diseases: current knowledge and the road ahead.
    Condorelli G; Latronico MV; Cavarretta E
    J Am Coll Cardiol; 2014 Jun; 63(21):2177-87. PubMed ID: 24583309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-based therapeutic approaches in the cardiovascular system.
    Fiedler J; Gupta SK; Thum T
    Cardiovasc Ther; 2012 Feb; 30(1):e9-e15. PubMed ID: 20946325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
    Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
    Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic advances in MicroRNA targeting.
    Montgomery RL; van Rooij E
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):1-7. PubMed ID: 20729755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
    Calway T; Kim GH
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):131-43. PubMed ID: 25261390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis.
    Wang J; Liew OW; Richards AM; Chen YT
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel techniques and targets in cardiovascular microRNA research.
    Dangwal S; Bang C; Thum T
    Cardiovasc Res; 2012 Mar; 93(4):545-54. PubMed ID: 22072632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of microRNAs in diagnosis and treatment of cardiovascular disease.
    Wronska A; Kurkowska-Jastrzebska I; Santulli G
    Acta Physiol (Oxf); 2015 Jan; 213(1):60-83. PubMed ID: 25362848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of microRNAs in cardiovascular disease.
    Maegdefessel L
    J Intern Med; 2014 Dec; 276(6):633-44. PubMed ID: 25160930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: role in cardiovascular biology and disease.
    Zhang C
    Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cardiovascular microRNA targetomes.
    Fiedler J; Gupta SK; Thum T
    J Mol Cell Cardiol; 2011 Nov; 51(5):674-81. PubMed ID: 21888912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Involvement of miRNA in Carotid-Related Stroke.
    Maitrias P; Metzinger-Le Meuth V; Nader J; Reix T; Caus T; Metzinger L
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1608-1617. PubMed ID: 28775076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting microRNAs for cardiovascular therapeutics in coronary artery disease.
    Hinkel R; Ng JK; Kupatt C
    Curr Opin Cardiol; 2014 Nov; 29(6):586-94. PubMed ID: 25159281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet miRNAs and cardiovascular diseases.
    Fuentes E; Palomo I; Alarcón M
    Life Sci; 2015 Jul; 133():29-44. PubMed ID: 26003375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of microRNAs for therapeutics.
    Stenvang J; Lindow M; Kauppinen S
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1197-200. PubMed ID: 19021524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.